Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical Developments

Gliomas are one of the most lethal types of cancers accounting for ∼80% of all central nervous system (CNS) primary malignancies. Among gliomas, glioblastomas (GBM) are the most aggressive, characterized by a median patient survival of fewer than 15  months. Recent molecular characterization studies...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron: Mahmoud S. Alghamri, Brandon L. McClellan, Carson S. Hartlage, Santiago Haase, Syed Mohd Faisal, Rohit Thalla, Ali Dabaja, Kaushik Banerjee, Stephen V. Carney, Anzar A. Mujeeb, Michael R. Olin, James J. Moon, Anna Schwendeman, Pedro R. Lowenstein, Maria G. Castro
Fformat: Erthygl
Iaith:English
Cyhoeddwyd: Frontiers Media S.A. 2021-05-01
Cyfres:Frontiers in Pharmacology
Pynciau:
Mynediad Ar-lein:https://www.frontiersin.org/articles/10.3389/fphar.2021.680021/full

Eitemau Tebyg